Skip to main content
. Author manuscript; available in PMC: 2015 Sep 16.
Published in final edited form as: Biomaterials. 2011 Jan 22;32(11):3094–3105. doi: 10.1016/j.biomaterials.2010.12.054

Fig. 1.

Fig. 1

Description of nanoparticles. (A) Schematic representation of nanoparticles surface modified with avidin to facilitate binding of a biotinylated ligand (not to scale). (B) Scanning electron microscopy image of surface modified nanoparticles. (C) Measurement of size and polydispersity of unmodified and surface modified nanoparticles by dynamic light scattering.